Status:

COMPLETED

Norepinephrine to Prevent Hypotension in Ceasrean Delivery

Lead Sponsor:

Menoufia University

Conditions:

Hypotension

Cesarean Section Complications

Eligibility:

FEMALE

18-35 years

Phase:

PHASE4

Brief Summary

This study will be conducted on 40 healthy women having spinal anesthesia for elective cesarean delivery in the operating rooms at Menoufia university hospital.

Detailed Description

Informed written consent will be taken from all subjects included in the study after approval of the study by the local ethical committee. All subjects will be subjected to thorough history taking wi...

Eligibility Criteria

Inclusion

  • ASA I \& II
  • Non laboring
  • Normotensive
  • Elective cesarean delivery under spinal anesthesia.
  • Baseline systolic blood pressure 90-140 mm Hg

Exclusion

  • Known fetal abnormality.
  • Preexisting or pregnancy-induced hypertension.
  • Known cardiovascular or cerebrovascular disease.
  • Thrombocytopenia, coagulopathy or any contraindication to spinal anesthesia.
  • Weight \<50 or \>100 kg, height \<140 or \>180 cm.
  • Inability or refusal to give informed consent

Key Trial Info

Start Date :

January 20 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 20 2022

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT05248932

Start Date

January 20 2021

End Date

June 20 2022

Last Update

October 14 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Faculty of Medicine, University Hospitals

Shibīn al Kawm, Menoufia, Egypt, 32511

Norepinephrine to Prevent Hypotension in Ceasrean Delivery | DecenTrialz